Laboratory Corporation of America Holdings (LH): Interesting things to know About LH


Laboratory Corporation of America Holdings (NYSE:LH) changes shares on Tuesday trading session, with a change of -0.64% or -$1.25 shares. The trading starts at $195.19 and closed at $196.02 throughout the day. The trading session low price was $192.99 and day high was $196.39 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.47 million while its average volume is 826.37K. In other hand, the LH market cap reached to $19.12B. While, its current target price is $228.14.

On July 28, 2020, LabCorp says needs to run testing below full capacity for faster results. According to the news reported on Reuters, Laboratory Corporation of America Holdings said on Tuesday it has the capacity to run about 180,000 molecular tests a day and was delivering results in two-three days, but to maintain the speed it will have to perform below full capacity.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -0.90% and up 12.85% for month. Its quarterly performance was 19.67% above, while its half year performance is up 6.72%. LH yearly performance stood at positive 21.91% and rise 15.13% for year-to-date. Current recommendation for Laboratory Corporation of America Holdings is 1.80.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. LH EPS (TTM) for 12-month is 3.67. EPS for this year is -7.70%, while for the next year its value is 15.23. Sales growth for the current quarter is 6.39 while its EPS Q/Q reached -274.90%. It has an EPS of 7.10% up for past five years and for the next five years will be up 8.30%.

Let’s take a look on the analyst recommendations on LH for the current month and previous month. For the current month, 15 of 19 analysts recommend stock as Buy while 0 as Sell, 1 as overweight, 0 as underweight and 3 as Hold. As compared with the previous month ratings, 19 analysts participate in stock recommendation. Out of 19, 0 rated it sell, 13 rated it as Buy and 4 as Hold Ratings. On the other hand, target price ranges from $183.00 – $249.00. Average target price for LH was reached at $228.20.

The insider ownership moved to 0.50% and institutional holding shifted to 93.70%.

The company posted an EPS (TTM) of 3.67. According to the most recent quarter report on (Sep 2020), 12 analysts estimated an average EPS of 4.95, while 2.9 EPS posted a year ago period. Analyst Estimated EPS for LH published in the report was $3.62 – $6.52 during the same period. Comparing with last year, the average estimated EPS was 2.9 which is higher than 2.57 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for LH rise 15.89% for period of 200 days. SMA for 50 days was 9.20% which is showing green signal, while SMA-20 was 2.55%. The moving average value for Laboratory Corporation of America Holdings (LH) is 1.84M and 1.75% for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in LH stock. On Jul 08, Williams R Sanders, Director, sold 1,300 trading shares at the cost of $173.12, which valued at 0.23 million. On Jul 02, van der Vaart Sandra D, EVP, Chief Legal Officer, sold 435 shares at the cost of $170.00, with total shares of 4,044. On Jun 24, van der Vaart Sandra D, EVP, Chief Legal Officer, sold 872 shares at the cost of 160.33. After this transaction, van der Vaart Sandra D total shares reached to 4,479 which valued at 0.14 million.